Literature DB >> 11705134

Novel basic and clinical aspects of congenital adrenal hyperplasia.

D P Merke1, C A Camacho.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705134     DOI: 10.1023/a:1011520600476

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  39 in total

1.  Adrenal lymphocytic infiltration and adrenocortical tumors in a patient with 21-hydroxylase deficiency.

Authors:  D P Merke; S R Bornstein; D Braddock; G P Chrousos
Journal:  N Engl J Med       Date:  1999-04-08       Impact factor: 91.245

2.  Further studies on the treatment of congenital adrenal hyperplasia with cortisone. IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism.

Authors:  J F CRIGLER; S H SILVERMAN; L WILKINS
Journal:  Pediatrics       Date:  1952-10       Impact factor: 7.124

Review 3.  Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Y Morel; W L Miller
Journal:  Adv Hum Genet       Date:  1991

4.  The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.

Authors:  O H Pescovitz; F Comite; K Hench; K Barnes; A McNemar; C Foster; D Kenigsberg; D L Loriaux; G B Cutler
Journal:  J Pediatr       Date:  1986-01       Impact factor: 4.406

5.  Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice.

Authors:  S R Bornstein; T Tajima; G Eisenhofer; A Haidan; G Aguilera
Journal:  FASEB J       Date:  1999-07       Impact factor: 5.191

6.  Glucocorticoid induction of tyrosine hydroxylase in a continous cell line of rat pheochromocytoma.

Authors:  R Goodman; D Edgar; H Thoenen; W Wechsler; H Herschman
Journal:  J Cell Biol       Date:  1978-07       Impact factor: 10.539

7.  Survival of steroid 21-hydroxylase-deficient mice without endogenous corticosteroids after neonatal treatment and genetic rescue by transgenesis as a model system for treatment of congenital adrenal hyperplasia in humans.

Authors:  H Gotoh; M Kusakabe; T Shiroishi; K Moriwaki
Journal:  Endocrinology       Date:  1994-10       Impact factor: 4.736

8.  Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening.

Authors:  R M Lebovitz; R M Pauli; R Laxova
Journal:  Am J Dis Child       Date:  1984-06

9.  Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  L Ghizzoni; R Virdis; A Vottero; M Cappa; M E Street; M Zampolli; L Ibañez; S Bernasconi
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

10.  Dating the primigenial C4-CYP21 duplication in primates.

Authors:  Y Horiuchi; H Kawaguchi; F Figueroa; C O'hUigin; J Klein
Journal:  Genetics       Date:  1993-05       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.